Complete Filing Data
LIPELLA PHARMACEUTICALS INC. reported Stockholders Equity of $4.68 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean LIPELLA PHARMACEUTICALS INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income Loss | -$5.0M | -$4.6M | -$2.6M | -$1.9M |
| Research And Development Expense | $3.6M | $3.0M | $2.5M | $1.5M |
| Operating Income Loss | -$5.1M | -$4.7M | -$2.6M | -$1.9M |
| Nonoperating Income Expense | $64.3K | $127.0K | -$8.0K | $50.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.0M | -$4.6M | -$2.6M | -$1.9M |
| General And Administrative Expense | $2.0M | $2.2M | $226.2K | $718.4K |
| Revenues | $536.4K | $449.6K | $184.2K | $259.3K |
| Interest Expense | $10.8K | $9.6K | $6.8K | |
| Interest Expense Other | $9.6K | $6.8K | ||
| Other Nonoperating Income Expense | ||||
| Income Taxes Paid Net | -$11.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$1.3M | -$1.3M | -$1.3M | -$1.4M | -$938.1K | -$1.2M | -$1.3M | -$1.5M | -$1.1M | -$713.8K | -$782.0K | -$738.0K |
| Research And Development Expense | $721.0K | $791.6K | $993.5K | $1.0M | $661.6K | $842.6K | $833.3K | $1.1M | $693.7K | $651.0K | $742.7K | $676.0K |
| Operating Income Loss | -$1.3M | -$1.4M | -$1.3M | -$1.5M | -$952.2K | -$1.2M | -$1.4M | -$1.6M | -$1.1M | -$712.6K | -$781.1K | -$736.7K |
| Nonoperating Income Expense | $20.2K | $29.1K | $21.3K | $14.8K | $14.0K | $25.8K | $33.2K | $36.5K | $16.6K | -$1.2K | -$877.00 | -$1.3K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.3M | -$1.3M | -$1.3M | -$1.4M | -$938.1K | -$1.2M | -$1.3M | -$1.5M | -$1.1M | -$713.8K | -$782.0K | -$738.0K |
| General And Administrative Expense | $553.3K | $651.7K | $463.7K | $493.1K | $427.1K | $520.9K | $627.5K | $624.2K | $508.8K | $61.7K | $38.5K | $93.9K |
| Revenues | $86.7K | $129.4K | $80.4K | $136.4K | $145.9K | $104.1K | $106.7K | $118.0K | $33.1K | |||
| Interest Expense | $5.5K | $5.4K | $1.7K | $1.6K | $1.6K | |||||||
| Interest Expense Other | $5.4K | $1.6K | ||||||||||
| Other Nonoperating Income Expense | $156.00 | -$201.00 | ||||||||||
| Income Taxes Paid Net | $6.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity | $4.7M | $1.4M | $463.3K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.1M | $1.4M | $606.7K | ||
| Retained Earnings Accumulated Deficit | -$10.3M | -$5.7M | -$3.1M | ||
| Payroll Liability | $80.8K | $67.8K | $50.2K | ||
| Operating Lease Right Of Use Asset | $135.1K | $150.8K | $204.8K | ||
| Operating Lease Liability Current | $89.2K | $58.3K | $39.6K | ||
| Liabilities Current | $385.4K | $1.2M | $340.6K | ||
| Liabilities And Stockholders Equity | $3.6M | $6.0M | $2.0M | ||
| Liabilities | $432.7K | $1.3M | $589.3K | ||
| Common Stock Value | $75.00 | $574.00 | $387.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.1M | -$1.8M | $3.7M | $807.1K | |
| Cash And Cash Equivalents At Carrying Value | $3.3M | $5.1M | $1.4M | ||
| Assets Current | $3.4M | $5.8M | $1.8M | ||
| Assets | $3.6M | $6.0M | $2.0M | ||
| Accrued Liabilities Current | $77.3K | $389.2K | $151.5K | ||
| Accounts Payable Current | $138.0K | $384.4K | $46.9K | ||
| Operating Lease Liability Noncurrent | $47.4K | $96.3K | $168.4K | ||
| Accounts Receivable Net Current | $84.7K | $32.3K | $113.7K | ||
| Property Plant And Equipment Net | $12.8K | ||||
| Operating Lease Right Of Use Asset1 | -$2.2K | $538.00 | |||
| Repayments Of Notes Payable | $25.0K | ||||
| Other Liabilities Current | $250.0K | $25.0K | |||
| Stock Issued During Period Value Issuance Of Common Stocks | $200.0K | ||||
| Notes Payable Current | $25.0K | ||||
| Grants Receivable Current | |||||
| Other Assets | $135.1K | $150.8K | |||
| Issuance Of Preferred Stock And Warrants Net Of Issuance Costs | $1.8M | ||||
| Repayment Of Notes Payable Related Party | $250.0K | ||||
| Issuance Of Warrants To Purchase Series B Preferred Stock |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.5M | $2.7M | $4.1M | $1.9M | $1.5M | $1.7M | $2.6M | $3.1M | $2.2M | $3.1M | $3.8M | -$62.8K | $352.2K | $920.8K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.9M | $2.8M | $4.2M | $2.2M | $1.4M | $1.2M | $2.1M | $3.3M | $2.4M | $3.1M | $4.0M | $114.8K | $435.0K | $414.4K |
| Retained Earnings Accumulated Deficit | -$19.2M | -$18.0M | -$16.6M | -$15.3M | -$13.9M | -$12.5M | -$11.5M | -$9.6M | -$8.3M | -$6.8M | ||||
| Payroll Liability | $100.3K | $80.8K | $102.4K | $80.7K | $81.1K | $81.3K | $81.4K | $82.3K | $77.3K | $68.8K | ||||
| Operating Lease Right Of Use Asset | $262.8K | $274.5K | $23.6K | $46.8K | $69.6K | $92.0K | $114.0K | $156.4K | $122.5K | $136.8K | ||||
| Operating Lease Liability Current | $44.3K | $42.9K | $24.0K | $47.6K | $70.8K | $93.7K | $91.7K | $87.3K | $60.8K | $59.5K | ||||
| Liabilities Current | $642.4K | $746.9K | $776.8K | $754.4K | $701.2K | $480.3K | $551.9K | $548.7K | $298.8K | $717.4K | ||||
| Liabilities And Stockholders Equity | $2.3M | $3.7M | $4.9M | $2.7M | $2.2M | $2.2M | $3.1M | $2.8M | $3.5M | $4.6M | ||||
| Liabilities | $862.2K | $978.5K | $776.8K | $754.4K | $701.2K | $480.3K | $575.9K | $619.2K | $364.2K | $798.4K | ||||
| Common Stock Value | $462.00 | $446.00 | $254.00 | $121.00 | $109.00 | $761.00 | $704.00 | $580.00 | $574.00 | $574.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $2.0M | -$1.2M | -$1.1M | -$999.4K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $1.9M | $2.8M | $4.2M | $2.2M | $1.4M | $1.2M | $2.1M | $2.4M | $3.1M | $4.0M | ||||
| Assets Current | $2.1M | $3.4M | $4.8M | $2.6M | $2.1M | $2.1M | $3.0M | $2.7M | $3.4M | $4.5M | ||||
| Assets | $2.3M | $3.7M | $4.9M | $2.7M | $2.2M | $2.2M | $3.1M | $2.8M | $3.5M | $4.6M | ||||
| Accrued Liabilities Current | $34.9K | $15.1K | $258.3K | $237.9K | $89.8K | $127.0K | $84.9K | $76.1K | $138.7K | $181.2K | ||||
| Accounts Payable Current | $462.9K | $608.1K | $392.1K | $388.2K | $459.5K | $178.4K | $293.8K | $303.1K | $22.1K | $148.9K | ||||
| Operating Lease Liability Noncurrent | $219.8K | $231.6K | $24.0K | $70.5K | $65.4K | $80.9K | ||||||||
| Accounts Receivable Net Current | $31.1K | $35.3K | $68.9K | $53.1K | $28.0K | $84.0K | ||||||||
| Property Plant And Equipment Net | $7.7K | $8.4K | $9.1K | $9.9K | $10.6K | $11.3K | $12.0K | $13.5K | ||||||
| Operating Lease Right Of Use Asset1 | $214.00 | -$34.00 | $403.00 | |||||||||||
| Repayments Of Notes Payable | $25.0K | |||||||||||||
| Other Liabilities Current | $250.0K | |||||||||||||
| Stock Issued During Period Value Issuance Of Common Stocks | $200.0K | |||||||||||||
| Notes Payable Current | ||||||||||||||
| Grants Receivable Current | $42.0K | $85.6K | $84.7K | |||||||||||
| Other Assets | $156.4K | |||||||||||||
| Issuance Of Preferred Stock And Warrants Net Of Issuance Costs | $3.5M | |||||||||||||
| Repayment Of Notes Payable Related Party | ||||||||||||||
| Issuance Of Warrants To Purchase Series B Preferred Stock | $9.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.0M | -$3.2M | -$1.8M | -$989.3K |
| Increase Decrease In Prepaid Expense | $244.4K | -$460.6K | $470.2K | $70.1K |
| Increase Decrease In Deferred Liabilities | -$100.00 | $13.0K | $17.7K | $22.9K |
| Increase Decrease In Accrued Liabilities | $160.6K | -$315.5K | $237.7K | $151.5K |
| Increase Decrease In Accounts Payable | $250.2K | -$246.3K | $337.5K | $22.4K |
| Net Cash Provided By Used In Financing Activities | $2.8M | $1.3M | $5.2M | $2.1M |
| Increase Decrease In Grants Receivable | $52.4K | -$81.4K | $113.7K | -$69.0K |
| Proceeds From Issuance Of Common Stock | $5.0M | $2.1M | ||
| Stock Issued During Period Value Share Based Compensation | $749.4K | $1.4M | $747.4K | $728.8K |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $127.5K | $125.9K | ||
| Depreciation Depletion And Amortization | $2.9K | $1.7K | ||
| Net Cash Provided By Used In Investing Activities | -$14.4K | $300.5K | -$300.5K | |
| Payments To Acquire Marketable Securities1 | -$300.5K | $300.5K | ||
| Payments To Acquire Property Plant And Equipment | $14.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.4M | -$1.4M | -$1.1M | -$699.4K | |||||||
| Increase Decrease In Prepaid Expense | $165.0K | $733.6K | -$188.6K | $221.0K | |||||||
| Increase Decrease In Deferred Liabilities | $21.7K | $576.00 | $997.00 | $473.00 | |||||||
| Increase Decrease In Accrued Liabilities | $20.4K | $7.6K | -$208.0K | $12.3K | |||||||
| Increase Decrease In Accounts Payable | $3.9K | $155.8K | -$235.4K | $9.6K | |||||||
| Net Cash Provided By Used In Financing Activities | $3.5M | $200.0K | -$25.0K | ||||||||
| Increase Decrease In Grants Receivable | $918.00 | $36.6K | -$29.7K | ||||||||
| Proceeds From Issuance Of Common Stock | $3.5M | $200.0K | |||||||||
| Stock Issued During Period Value Share Based Compensation | $379.4K | $80.7K | $208.6K | $298.8K | $847.6K | $208.6K | |||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $132.6K | $131.9K | $131.2K | $130.4K | $129.7K | $129.0K | $128.3K | $126.8K | |||
| Depreciation Depletion And Amortization | $722.00 | $721.00 | |||||||||
| Net Cash Provided By Used In Investing Activities | -$300.0K | ||||||||||
| Payments To Acquire Marketable Securities1 | $300.0K | ||||||||||
| Payments To Acquire Property Plant And Equipment |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.0M | 750.4K | 4.1M | 3.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.0M | 750.4K | 4.1M | 3.4M |
| Earnings Per Share Diluted | $-4.79 | $-6.16 | $-0.64 | $-0.55 |
| Earnings Per Share Basic | $-4.79 | $-6.16 | $-0.64 | $-0.55 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 756.7K | 5.7M | 3.9M | |
| Common Stock Shares Issued | 756.7K | 5.7M | 3.9M | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 1.6M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 4.5M | 4.3M | 2.1M | 1.1M | 950.7K | 911.5K | 719.2K | 5.7M | 5.7M | 4.1M | 3.9M | 3.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 4.5M | 4.3M | 2.1M | 1.1M | 950.7K | 911.5K | 719.2K | 5.7M | 5.7M | 4.1M | 3.9M | 3.9M | |
| Earnings Per Share Diluted | $-0.28 | $-0.31 | $-0.64 | $-1.29 | $-0.99 | $-1.31 | $-1.84 | $-0.27 | $-0.19 | $-0.17 | $-0.20 | $-0.19 | |
| Earnings Per Share Basic | $-0.28 | $-0.31 | $-0.64 | $-1.29 | $-0.99 | $-1.31 | $-1.84 | $-0.27 | $-0.19 | $-0.17 | $-0.20 | $-0.19 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 4.6M | 4.5M | 2.5M | 1.2M | 1.1M | 7.6M | 7.0M | 5.8M | 5.7M | 5.7M | |||
| Common Stock Shares Issued | 4.6M | 4.5M | 2.5M | 1.2M | 1.1M | 7.6M | 7.0M | 5.8M | 5.7M | 5.7M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Costs And Expenses | $5.6M | $5.2M | $2.8M | $2.2M |
| Investment Income Interest | $64.3K | $137.8K | $1.7K | $104.00 |
| Prepaid Expense Current | $103.3K | $563.9K | $93.7K | |
| Additional Paid In Capital | $13.5M | $10.4M | $4.5M | |
| Noncash Contribution Expense | $749.4K | $1.4M | $747.4K | $728.8K |
| Stock Issued During Period Value Issued For Services | $200.0K | $121.2K | ||
| Furniture And Fixtures Gross | $140.3K | $125.9K | ||
| Operating Right Of Use Asset1 | -$599.00 | -$2.2K | ||
| Interest Paid Net | $11.9K | $11.4K | ||
| Issuance Of Stock And Warrants For Services Or Claims | $200.0K | $121.2K | ||
| Stock Issued During Period Value New Issues | $388.4K | |||
| Related Party Interest | $3.6K | $27.4K | ||
| Other Income | -$45.00 | $57.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $1.3M | $1.4M | $1.5M | $1.5M | $1.1M | $1.4M | $1.5M | $1.7M | $1.2M | $712.6K | $781.1K | $769.8K | |
| Investment Income Interest | $20.2K | $29.1K | $21.3K | $14.8K | $14.0K | $25.8K | $33.2K | $42.0K | $22.0K | $501.00 | $603.00 | $532.00 | |
| Prepaid Expense Current | $223.5K | $613.4K | $512.7K | $347.7K | $695.2K | $859.0K | $836.9K | $208.1K | $225.3K | $375.3K | |||
| Additional Paid In Capital | $20.7M | $20.7M | $20.7M | $17.3M | $15.4M | $14.2M | $14.1M | $11.9M | $11.4M | $10.6M | |||
| Noncash Contribution Expense | $208.6K | $208.6K | $235.1K | ||||||||||
| Stock Issued During Period Value Issued For Services | $200.0K | $121.2K | $847.6K | $208.6K | $298.8K | $213.5K | $235.1K | ||||||
| Furniture And Fixtures Gross | $140.3K | $140.3K | $140.3K | $140.3K | $140.3K | $140.3K | $140.3K | $140.3K | |||||
| Operating Right Of Use Asset1 | -$424.00 | $215.00 | |||||||||||
| Interest Paid Net | $4.2K | $6.2K | |||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $200.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $468.6K | $80.7K | $208.6K | $847.6K | $208.6K | $235.1K | |||||||
| Related Party Interest | $9.0K | ||||||||||||
| Other Income |
Most recent annual filing with the SEC: March 28, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.